Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis

Romée J. A. L. M. Snijders; Tom J. G. Gevers; Michael A. Heneghan; Joost P. H. Drenth

doi:10.1016/j.jhep.2022.07.025

Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis

Romée J. A. L. M. Snijders^*, Tom J. G. Gevers, Michael A. Heneghan, Joost P. H. Drenth

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Original language	English
Pages (from-to)	1464-1466
Journal	Journal of hepatology
Volume	77
Issue number	5
DOIs	https://doi.org/10.1016/j.jhep.2022.07.025
Publication status	Published - 1 Nov 2022
Externally published	Yes

Access to Document

10.1016/j.jhep.2022.07.025

Cite this

Snijders, R. J. A. L. M., Gevers, T. J. G., Heneghan, M. A., & Drenth, J. P. H. (2022). Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis. Journal of hepatology, 77(5), 1464-1466. https://doi.org/10.1016/j.jhep.2022.07.025

Snijders, Romée J. A. L. M. ; Gevers, Tom J. G. ; Heneghan, Michael A. et al. / Reply to : “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis. In: Journal of hepatology. 2022 ; Vol. 77, No. 5. pp. 1464-1466.

@article{5d4e597d74f34327a5e2128c5a0d3903,

title = "Reply to: “Correspondence on {\textquoteleft}Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group{\textquoteright}”: Defining endpoints that guide treatment in autoimmune hepatitis",

author = "Snijders, {Rom{\'e}e J. A. L. M.} and Gevers, {Tom J. G.} and Heneghan, {Michael A.} and Drenth, {Joost P. H.}",

year = "2022",

month = nov,

day = "1",

doi = "10.1016/j.jhep.2022.07.025",

language = "English",

volume = "77",

pages = "1464--1466",

journal = "Journal of hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "5",

}

Snijders, RJALM, Gevers, TJG, Heneghan, MA & Drenth, JPH 2022, 'Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis', Journal of hepatology, vol. 77, no. 5, pp. 1464-1466. https://doi.org/10.1016/j.jhep.2022.07.025

Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis. / Snijders, Romée J. A. L. M.; Gevers, Tom J. G.; Heneghan, Michael A. et al.
In: Journal of hepatology, Vol. 77, No. 5, 01.11.2022, p. 1464-1466.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Reply to

T2 - “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis

AU - Snijders, Romée J. A. L. M.

AU - Gevers, Tom J. G.

AU - Heneghan, Michael A.

AU - Drenth, Joost P. H.

PY - 2022/11/1

Y1 - 2022/11/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85139180769&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/35985543

U2 - 10.1016/j.jhep.2022.07.025

DO - 10.1016/j.jhep.2022.07.025

M3 - Comment/Letter to the editor

C2 - 35985543

SN - 0168-8278

VL - 77

SP - 1464

EP - 1466

JO - Journal of hepatology

JF - Journal of hepatology

IS - 5

ER -

Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis

Access to Document

Other files and links

Cite this